Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|July 17, 2020
<i>CDK12</i>-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint BlockadeMichael T Schweizer, Gavin Ha, Roman Gulati, et al.
Human Mutation|September 2, 2022
de novo variant calling identifies cancer mutation signatures in the 1000 Genomes ProjectJeffrey K Ng, Pankaj Vats, Elyn Fritz-Waters, et al.
The Journal of Clinical Investigation|January 17, 2018
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regressionHeng Lin, Shuang Wei, Elaine M Hurt, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy responseYuping Zhang, Sathiya P Narayanan, Rahul Mannan, et al.
Nature Genetics|September 14, 2023
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronismJuilee Rege, Sascha Bandulik, Kazutaka Nanba, et al.
Cancer Research|August 5, 2015
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell CarcinomaPaul William Harms, Pankaj Vats, Monique Elise Verhaegen, et al.
Cell|June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate CancerYi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Cancer Discovery|September 9, 2016
Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the KidneyRohit Mehra, Pankaj Vats, Marcin Cieslik, et al.
Nature Communications|June 6, 2020
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer developmentSunita Shankar, Jean Ching-Yi Tien, Ronald F Siebenaler, et al.
Pageof 6